Amoxicillin Quality and Selling Practices in Urban Pharmacies and Drug Stores of Blantyre, Malawi
- PMID: 29692302
- PMCID: PMC6085786
- DOI: 10.4269/ajtmh.18-0003
Amoxicillin Quality and Selling Practices in Urban Pharmacies and Drug Stores of Blantyre, Malawi
Abstract
This study evaluated a newly developed paper analytical device (PAD) for screening amoxicillin samples in Blantyre urban townships. Covert shoppers attempted to buy amoxicillin from a geographically stratified selection of private pharmacies (N = 22 out of 26) and drug stores (N = 23 out of 103) in the township area. According to the PAD results, all 42 samples obtained by the shoppers contained amoxicillin and none contained suspicious filler materials. Next, the products were assayed using high-performance liquid chromatography. Consistent with the PAD results, all samples contained the correct amount of amoxicillin with no unexpected ingredients. However, one sample was purchased as amoxicillin and contained that ingredient, but was packaged in capsules that are normally used to package ampicillin. Almost every sample failed a simple packaging analysis. Nine in 10 samples were missing their original packaging and/or inserts (52.4% repackaged capsules and 35.7% repackaged blister packs). Only 33.3% of the packages had expiry dates, 16.7% had batch numbers, and 47.6% had the manufacturer's name. Dispensing practices were likewise unsatisfactory. Ninety-five percentage of the sellers sold the amoxicillin without a prescription, even though this medicine is regulated as prescription-only in Malawi. Although the chemical analysis showed that amoxicillin quality was good, our market survey revealed poor adherence to prescription-only medicine dispensing of antibiotics, which threatens antimicrobial stewardship efforts. Furthermore, the wide prevalence of repackaging deprives medicines of important information needed during patient's use, regulatory investigations, and pharmacovigilance reporting.
Conflict of interest statement
Ethical considerations: The study was conducted with permission from the Pharmacy, Medicines and Poisons Board (PMPB) of Malawi and approval by the College of Medicine Research and Ethics Committee (COMREC, Ref P.06/16/1975) and by the University of Notre Dame Institutional Review Board (15-05-2542).
Declarations: One author, M. L., holds a patent (US 009354181B2) on the paper analytical devices (PADs) used to perform field screening of the amoxicillin samples in this study. Licensing negotiations for this patent with a U.S. company are underway. The U.S. patent will not prevent others from manufacturing or selling PADs outside the United States, and M. L. has no international patents or patent applications on the PAD technology.
Conflicts of interest: ML and IC received joint funding from Indiana Clinical and Translational Science Institute (CTSI) to carry out this study. The other authors declare that they do not have any competing interests or conflicts of interest.
Figures
References
-
- World Health Organization , 2017. Definitions of Substandard and Falsified (SF) Medical Products Available at: http://www.who.int/medicines/regulation/ssffc/defintions/en/. Accessed January 22, 2018.
-
- Trapsida JM, Desta AT, Kasilo O, 2012. Preventing and Controlling Substandard and Counterfeit Medical Products in the Who African Region. World Health Organization, Regional Office for Africa. Brazzaville, Republic of Congo: African Health Monitor.
-
- Osei-Safo D, Harrison JJEK, Addae-Mensah I, 2010. Validation and application of quality assurance methods developed for artemisinin-based anti-malarial drugs to assess the quality of a selection of such drugs distributed in Accra, Ghana. Afr J Pharm Sci Pharm 1: 1–25.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
